C. Light Technologies, Inc. is revolutionizing the way we detect, monitor, and treat multiple sclerosis (MS) through the use of a patented, non-invasive, IRB-approved retinal eye-tracker - the tracking scanning laser ophthalmoscope (TSLO) with accompanying machine learning algorithms. In the future, our vision is to use the TSLO for other applications, including concussions, Parkinson’s, ALS, and Alzheimer’s.
News
C. Light Raises $100K in Angel Investment
(2/1/2016)
$575K NIH Grant Funding Awarded
(6/2017 & 3/2018)
Audience Choice & 2nd Place Winners - Haas Healthcare Pitch
(3/2018)
Accepted to CLSI FAST Program
(4/2018)
Collaborators
